Skip to main content
OpenTrials
Completed

NCT Number: NCT00744068

Four Models of Telephone Support for Stimulant Recovery

The overall objective of this research is to develop and refine empirically supported continuing care interventions that promote healthy behavior and sustained abstinence from illicit drug use.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Twin Town Treatment Center, Los Alamitos, California, United States

Loading trial locations.

About this study

For treatment interventions to provide the desired result of long term abstinence, it is important to develop strategies to enhance the effectiveness of continued care approaches. We plan to conduct a prospective, randomized comparison of four models of counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program. Some 500 participants completing a 4-month Matrix Outpatient Model of stimulant abuse treatment will be randomly assigned to one of four counseling groups (n=100 per group): (1) unstructured/non-directive, (2) structured/non-directive, (3) unstructured/directive, or (4) structured/directive telephone counseling, or (5) a control group consisting of standard referral to Matrix aftercare, for a total sample size of 500. The two structured conditions will be based on the behavioral "prompts" identified by Farabee et al. (2002)* as being associated with drug avoidance. In the non-directive conditions, subjects will be allowed to state their own goals and how they intend to achieve them. In the directive conditions, the counselor will provide specific recommendations to help the subject adopt as many of the drug-avoidance activities as possible. Outcomes will be tracked for 12 months following completion of primary treatment (a total of 16 months after treatment admission) and will include measurement of participation in drug-avoidance activities (including aftercare participation) as well as self-reported and objective measures of substance use and related behavior change.

*Farabee, D., Rawson, R.A., & McCann, M. (2002). Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments. Journal of Substance Abuse Treatment, 23, 343-350.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Males or females, 18-65 years of age.
  • Meet DSM-IV criteria (at the time of treatment admission) for cocaine or methamphetamine abuse/dependence.
  • Have completed the primary phase of treatment at a Matrix outpatient clinic.
  • Have telephone access throughout the study procedures.
  • Be able to understand and complete rating scales and to follow instructions.
  • Be willing to sign an informed consent form.

Exclusion criteria

  • Have participated in a treatment-related study conducted by the PI and colleagues during the previous 3 years and/or is currently enrolled in a treatment-related study.
  • Have any medical, legal, housing or transportation problem which would preclude either safe or consistent participation.
  • Have dropped out of the primary phase of treatment prior to completion.

Treatment and study plan

Continuing Care Telephone Support

Behavioral

Counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program.

Primary outcomes

  1. Urinalyses

    Time frame: At 3 months and 12 months

  2. Breathalyzer tests

    Time frame: At 3 months and 12 months

  3. Self-report of drug or alcohol use

    Time frame: At 3 months and 12 months

  4. Amount of Treatment Activities

    Time frame: At 3 months and 12 months

  5. Length of Treatment Episode

    Time frame: At 3 months and 12 months

Secondary outcomes

  1. Addiction Severity Index (ASI)

    Time frame: At 3 months and 12 months

  2. HIV Risk-taking Behavior Scale

    Time frame: At 3 months and 12 months

  3. Concurrent Psychosocial Treatments

    Time frame: At 3 months and 12 months

  4. Drug Avoidance Activities (DAA) Survey

    Time frame: At 3 months and 12 months

Sponsors and collaborators

Lead sponsor

University of California, Los Angeles

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Important dates

Study start
2006
Primary completion
2010
Study completion
2011
First posted
Aug 29, 2008
Registry last updated
Nov 28, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.